Larimar Therapeutics (LRMR) Free Cash Flow (2016 - 2020)
Historic Free Cash Flow for Larimar Therapeutics (LRMR) over the last 8 years, with Q4 2020 value amounting to -$10.3 million.
- Larimar Therapeutics' Free Cash Flow fell 2880.29% to -$10.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$42.7 million, marking a year-over-year decrease of 8724.87%. This contributed to the annual value of -$71.3 million for FY2024, which is 11184.35% down from last year.
- Per Larimar Therapeutics' latest filing, its Free Cash Flow stood at -$10.3 million for Q4 2020, which was down 2880.29% from -$11.2 million recorded in Q3 2020.
- Larimar Therapeutics' Free Cash Flow's 5-year high stood at $3.5 million during Q2 2019, with a 5-year trough of -$18.2 million in Q1 2016.
- For the 5-year period, Larimar Therapeutics' Free Cash Flow averaged around -$10.7 million, with its median value being -$11.5 million (2017).
- In the last 5 years, Larimar Therapeutics' Free Cash Flow surged by 12612.28% in 2019 and then tumbled by 45014.35% in 2020.
- Over the past 5 years, Larimar Therapeutics' Free Cash Flow (Quarter) stood at -$8.7 million in 2016, then fell by 13.81% to -$9.9 million in 2017, then decreased by 20.11% to -$11.8 million in 2018, then soared by 32.8% to -$8.0 million in 2019, then decreased by 28.8% to -$10.3 million in 2020.
- Its last three reported values are -$10.3 million in Q4 2020, -$11.2 million for Q3 2020, and -$12.2 million during Q2 2020.